Olof Bengtsson

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi et al. · New England Journal of Medicine · 2019 · 6.4K citations · Full text

Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

Marc P. Bonaca, Deepak L. Bhatt, Marc Cohen et al. · New England Journal of Medicine · 2015 · 1.9K citations · Full text

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

Mark C. Petrie, Subodh Verma, Kieran F. Docherty et al. · JAMA · 2020 · 516 citations · Full text

A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF)

John J.V. McMurray, David L. DeMets, Silvio E. Inzucchi et al. · European Journal of Heart Failure · 2019 · 432 citations · Full text

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

Andreas Kindmark, A Jawaid, Chris Harbron et al. · The Pharmacogenomics Journal · 2007 · 365 citations

Genetic Epidemiology, Immunology, Pathology +17